Documentos de Académico
Documentos de Profesional
Documentos de Cultura
www.gu.se
Neuropsychiatric
Epidemiology
(Epinep)
Institute of Neuroscience and
Physiology Department of
Psychiatry and Neurochemistry
Sahlgrenska Academy at University
of Gothenburg, Sweden
www.epinep.gu.se
Senior researchers
Ingmar Skoog
Margda Waern
Tore Hllstrm
Svante stling
Pia Gudmundsson
Hanna Falk
Kerstin Frndin
Xinxin Guo
Anne Brjesson-Hanson
Silke Kern
Helena Hrder
Simona Sacuu
Lena Johansson
Anna Zetterberg
Jrgen Kern
Madeleine Mellqvist Fssberg
Eva Billstedt
Deborah Gustafson
Bjrn Karlsson
Stefan Wiktorsson
Nils Beckman
PhD students
Thorsteinn Gislasson
Johan Nilsson
Robert Sigstrm
Daniel Jaraj
Mats Ribbe
Scientific Coordinator
Pia Gudmundsson
Administrative Coordinator
Tina Jacobsson
Administrativ Assistant
Cecilia Mellqvist
Felicia Nord
Statisticians
Kristoffer Bckman
Erik Joas
Thomas Marlow
Valter Sundh
Research nurses
Carina Alklid
Fredrika Jnsson
Rebecca Ibstedt
Margareta Lewander
Helen Lidn
Birgitta Tengelin Widepalm
Malin Thorell
Bosse Svenningsson
Research trainees
Isak Fredn Klenfeldt
Therese Rydberg
Johan Skoog
Jenna Al-Najjar
Sahlgrenska akademin
Neuropsychiatric Epidemiology
EPINEP
Forskningsledare: Ingmar Skoog
www.gu.se
I. Skoog 2010
I. Skoog 2010
Dementia (DSM-IV)
A) Memory impairment
AND
B) One or more of the following.
a) aphasia
b) apraxia
c) agnosia
d) disturbance in executive function
C) Disturbance in social or occupational functioning
Prevalence of dementia
according to old criteria
(memory mandatory)
PROPORTION OF DIFFERENT
TYPES OF DEMENTIA
Alzheimers Disease
55-75%
Vascular Dementia
20-30%
Other dementias
10-20%
VASCULAR COGNITIVE
IMPAIRMENT
Cardiovascular and cerebrovascular
diseases causing cognitive
impairment
Includes both vascular dementia and
mild cognitive impairment
I. Skoog 2010
APA 2013
VASCULAR COGNITIVE
IMPAIRMENT
Cardiovascular and cerebrovascular
diseases causing cognitive
impairment
Includes both vascular dementia and
mild cognitive impairment
I. Skoog 2010
Kalaria 2013
Small-vessel disease
Arteriolosclerosis, Fibrinoid necrosis.
Microaneurysm. Fibrohyalinosis.
Lipohyalinosis. Microatheroma.
Cerebral amyloid angiopathy,
Segmental arterial disorganization
Small subcortical
infarcts
Diffuse white matter
lesions
From Kalaria 2013
Stroke
Silent cerebral infarcts
Lacunar infarcts
Microbleeds
Ischemic white matter
lesions
Vessel wall pathology
Vascular
risk factors
Hypertension
Overweight
ApoE e4
Hypercholesterolemia
Diabetes mellitus
Atherosclerosis
Coronary heart disease
Smoking
OR (95%-CI
No (%)
Yes (%)
70-80-year-olds
18
85-year-olds
(N=492)
24
57
4.3 ( 2.7-6.9)
97-year-olds
(N=592)
51
60
1.5 (1.0-2.3)
6.7 (2.6-17.6)
***
**
***
**
**
**
Silent infarcts
Ischemic white matter lesions
Co-occurrence of many different
cerebrovascular disorders in the same
individual (mixed cerebrovascular disorders)
Shared risk factors
Silent infarcts
Lacunar infarcts
Microbleeds
White matter lesions
Stroke
Silent cerebral
infarcts
Lacunar infarcts
Microbleeds
Ischemic white matter
lesions
Vessel wall pathology
Vascular
risk factors
Hypertension
Overweight
ApoE e4
Hypercholesterolemia
Diabetes mellitus
Atherosclerosis
Coronary heart disease
Smoking
OR
No infarcts/No history
1.0
Infarcts/No history
2.5*
(silent infarcts)
No infarcts/History
4.4*
Infarcts + History
5.2*
Liebetrau & Skoog. Stroke 2004
Stroke
Silent cerebral infarcts
Lacunar infarcts
Microbleeds
Ischemic white matter
lesions
Vessel wall pathology
Vascular
risk factors
Hypertension
Overweight
ApoE e4
Hypercholesterolemia
Diabetes mellitus
Atherosclerosis
Coronary heart disease
Smoking
Lacunes and
Lacunar infarcts
Lacunes
complete or cavitating infarcts; up
to 15 mm; common in subcortical
structures
Lacunar syndromes
Skoog 2013
Stroke
Silent cerebral infarcts
Lacunar infarcts
Microbleeds
Ischemic white matter
lesions
Vessel wall pathology
Vascular
risk factors
Hypertension
Overweight
ApoE e4
Hypercholesterolemia
Diabetes mellitus
Atherosclerosis
Coronary heart disease
Smoking
Cerebral microbleeds
Cerebral microbleeds
Skoog 2013
Cerebral microbleeds
Stroke
Silent cerebral infarcts
Lacunar infarcts
Microbleeds
Ischemic white matter
lesions
Vessel wall pathology
Vascular
risk factors
Hypertension
Overweight
ApoE e4
Hypercholesterolemia
Diabetes mellitus
Atherosclerosis
Coronary heart disease
Smoking
Demented
(N) %
Men (N=75)
37
Women (N=263)
56 *
Dementia
Mild cognitive symptoms
Depression
Functional disability
Gait disturbance and falls
Hip fracture
Urinary incontinence
Brain atrophy
Stroke and other vascular disease
High mortality rate
(95%-CI)
(per 1 SD increase
in WML score)
Dementia
1.67
(1.3-7.2)
(95%CI)
3.0
(1.3-7.2)
Depression 3.0
(1.0-9.2)
Dementia
Dementia
Mild cognitive symptoms
Depression
Functional disability
Gait disturbance and falls
Hip fracture
Urinary incontinence
Brain atrophy
Stroke and other vascular disease
High mortality rate
WMLs
Mean (N)
mean
Verbal ability
(76) 19
(36) 17
Visuospatial ability
(81) 13
(42)
Perceptual speed
(78) 14
(38) 12 *
9 **
Dementia
Mild cognitive symptoms
Depression
Functional disability
Gait disturbance and falls
Hip fracture
Urinary incontinence
Brain atrophy
Stroke and other vascular disease
High mortality rate
95%-CI
Periventricular
lesions
4.7
(2.0 to 11.2)
Subcortical lesions
3.6
(1.4 to 9.2)
Treatment implications?
Treat vascular risk factors
Antithrombotics? Aspirin?
The implication of microbleeds in a person with
stroke or TIA?
THE CONCEPT OF
MIXED DEMENTIA/
MIXED MCI
DEMENTIA IN INDIVIDUALS
WITH ALZHEIMER NEUROPATHOLGY
THE NUN STUDY
%
No infarcts
57
1-2 lacunar 93
Large infarct
75
Snowdon et al JAMA 1997
Alzheimers disease
?
Dementia
?
Mild cognitive
impairment
?
No dementia
Cerebrovascular disease
MIXED DEMENTIA/MCI
MIXED DEMENTIA
ALZHEIMERS DISEASE
CEREBROVASCULAR
DISEASE
OTHER TYPES
A Brjesson Hanson
MIXED DEMENTIA
ALZHEIMERS DISEASE
CEREBROVASCULAR
DISEASE
OTHER TYPES
A Brjesson Hanson
RR (95%-CI)
Non-demented
(N=307)
2.4 (1.2-4.6)
Demented (N=94)
3.8 (1.2-9.8)
Liebetrau & Skoog. Stroke 2008
DBP
OR
OR
1968
0.9 (0.8-1.1)
1.4 (1.1-1.8)
1974
0.9 (0.8-1.1)
1.3 (1.0-1.7)
1980
0.9 (0.8-1.0)
1.4 (1.1-1.8)
1992
1.0 (0.9-1.1)
1.3 (1.0-1.6)
Alzheimer disease
ApoE e4 (1993)
Hypertension (1996)
Hypercholesterolemia (1997)
Diabetes mellitus (1997)
Atherosclerosis (1997)
Overweight (2003)
ApoE e4 (1993)
Hypertension (1996)
Hypercholesterolemia (1997)
Diabetes mellitus (1997)
Atherosclerosis (1997)
Overweight (2003)
A 15-year follow-up of
blood pressure and Alzheimers disease
Demented
(N) %
Men (N=75)
37
Women (N=263)
56 *
Kuopio, Finland
Kivipelto et al. BMJ 2001
Kungsholmen Study
Qiu et al Arch Neurol 2003
Chinese Study
Wu et al Life Science 2003
ANTIHYPERTENSIVE DRUGS
AND RISK OF DEMENTIA
Kungsholmen (incidence) RR (95%-CI)
Dementia
0.7 (0.6-1.0)
(Guo et al. Arch Neurol 1999;56:991-996
Rotterdam (incidence)
RR (95%-CI)
Dementia
0.76 (0.52-1.12)
Vascular dementia
0.30 (0.11-0.99)
(In`t Veld et al. Neurobiol Aging. 2001;22:407-12 )
Cashe County (incidence) RR (95%-CI)
Alzheimers Disease 0.64 (0.41-0.98)
(Khachaturian et al. Arch Neurol 2006;63:686-92
ApoE e4 (1993)
Hypertension (1996)
Hypercholesterolemia (1997)
Diabetes mellitus (1997)
Atherosclerosis (1997)
Overweight (2003)
Women
1976-77
2005-06
1976-77
2000-01
83
74**
91
67***
Myocardial infarction
16
12
15*
Angina pectoris
12
6*
10
Stroke
12*
6*
TIA
Current smokers
32
11*
11*
Life-time smokers
64
65
10
42*
Women
1976-77
2005-06
1976-77
2000-01
Diabetes mellitus
11
16
11*
Overweight
47
67**
55
62
Obesity
17**
16
21*
Hypertension
76
61**
91
61**
Hypercholesterolemia
66
50**
85
74**
Joas et al 2013
2008-10
N=494
N=571
25
58 ***
PREVALENCE OF DEMENTIA IN
85-YEAR-OLDS 1986-87 AND
2008-10
1986-87
2008-10
N=494
N=571
31
24 *
1986-87
2008-9
Alzheimer
13
11
Vascular
14
Other
NEJM 1993
p<0.05
PREVALENCE OF STROKE IN
85-YEAR-OLDS 1986-87 AND
2008-10
1986-87
2008-10
N=494
N=571
16
30 **
1986-87
2008-9
No Stroke (%)
23
19
Stroke (%)
57
30
4.3 (2.7-6.9)
1.8 (1.2-2.7)
OR (95%-CI)
Brain imaging
ECG
Carotid ultrasonography
Blood screen (trombocytes, lipids, glucose etc)
Blood pressure
Therapeutic approach
Decrease stress
Good sleep
Physical activity, good lung function
Leisure time activity
Mentally stimulating activity
Social networking
Mediterrean diet
Healthy diet (cold water fatty fish, green leafy vegetables,
multivitamines)
Omega 3 fatty acids
(High sexual activity)
Red wine?
Acetylcholinesterase inhibitors
Donepezil
Rivastigmine
Galantamine
Black S et al. Stroke 2003;34:2323-30; Wilkinson D et al. Neurology 2003;61:479-86; Ogrogozo JM et al. Stroke 2002;33:1834-9; Erkinjuntti T et al. Lancet
2002;359:1283-90; Wilcock G, et al. Int Clin Psychopharmacol 2002;17:297-305; Auchus AP et al. Neurology 2007;69:448-58; Romn GC et al. Stroke
2010;41:1213-21.